MON-290 Ipilimumab Immune-Related ACTH Deficiency Is of Acute Onset and Severe

Introduction Immune checkpoint inhibitors (ICIs) are immunomodulatory molecules that downregulate T-cell inhibiting-receptors or ligands to promote an enhanced anti-tumour response. Ipilimumab is a human monoclonal antibody directed against cytotoxic T-lymphocyte antigen-4 (CTLA-4) that has been sho...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Endocr Soc
Autores principales: Seejore, Khyatisha, Giannoudi, Marilena, Osborn, Djoah, Lynch, Julie Marie, Dunwoodie, Elaine, Hook, Jane, Marples, Maria, Murray, Robert Douglas
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208295/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1486
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares